Holen Sie sich die Stockscreener-App
5.83
0.34%
0.02
Handel nachbörslich:
5.83
Schlusskurs vom Vortag:
$5.81
Offen:
$5.79
24-Stunden-Volumen:
8,892
Relative Volume:
0.30
Marktkapitalisierung:
$11.19M
Einnahmen:
$4.17M
Nettoeinkommen (Verlust:
$-50.71M
KGV:
-0.4327
EPS:
-13.474
Netto-Cashflow:
$-51.40M
1W Leistung:
+0.69%
1M Leistung:
-0.68%
6M Leistung:
-6.27%
1J Leistung:
-48.43%
1-Tages-Spanne:
$5.61
$5.94
1-Wochen-Bereich:
$5.50
$6.09
52-Wochen-Spanne:
$4.41
$11.70
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Firmenname
Bolt Biotherapeutics Inc
Sektor
Branche
Telefon
650-665-9295
Adresse
900 CHESAPEAKE DRIVE, REDWOOD CITY
Vergleichen Sie BOLT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.83 | 11.15M | 4.17M | -50.71M | -51.40M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-20 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-03-02 | Eingeleitet | Guggenheim | Buy |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
| 2021-03-02 | Eingeleitet | Stifel | Buy |
Alle ansehen
Bolt Biotherapeutics Inc Aktie (BOLT) Neueste Nachrichten
Will Bolt Biotherapeutics Inc. stock outperform tech sector in 2025Contrarian Investment Ideas & High Return Trading Strategies - bollywoodhelpline.com
How Bolt Biotherapeutics Inc. stock performs after earningsJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
Will Eversource Energy (NWJ) stock maintain strong growthWeekly Stock Report & AI Optimized Trading Strategy Guides - ulpravda.ru
Can Bolt Biotherapeutics Inc. stock continue upward trendWeekly Investment Summary & Real-Time Market Sentiment Alerts - ulpravda.ru
Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Earnings Overview Summary & Pattern Based Trade Signal System - ulpravda.ru
ulpravda ru > 2026> Is QLYS stock a buy on dipsEarnings Miss & Fast Gain Swing Alerts - ulpravda.ru
How supply shortages influence Bolt Biotherapeutics Inc. (6LP0) stockWeekly Trade Analysis & Low Risk Investment Opportunities - ulpravda.ru
Fundamentals Check: Can Bolt Biotherapeutics Inc. stock continue upward trend2025 Breakouts & Breakdowns & Verified Short-Term Plans - ulpravda.ru
Earnings Beat: Will Bolt Biotherapeutics Inc. stock reach all time highs in 2025Trade Entry Report & Free Technical Confirmation Trade Alerts - ulpravda.ru
Is Bolt Biotherapeutics Inc. stock supported by innovation pipelineJuly 2025 Update & Weekly High Return Opportunities - ulpravda.ru
SMA structure is bullish with the price reclaiming key MAs.Day Trading Setups & Affordable Market Strategies - ulpravda.ru
Is Bolt Biotherapeutics Inc. (6LP0) stock a fit for income portfolios2026 world cup usa national team quarterfinals goalkeepers set piece tactics expert forecast expert opinion - ulpravda.ru
Will Bolt Biotherapeutics Inc. (6LP0) stock enhance shareholder value2026 world cup usa national team semifinals defensive leaders set piece tactics knockout prediction breakdown - ulpravda.ru
Street Watch: Why Bolt Biotherapeutics Inc. stock could rally in 2025Trade Ideas & Short-Term Trading Alerts - moha.gov.vn
Performance Recap: Will STEM stock test record highs in 2025Earnings Miss & Technical Analysis for Trade Confirmation - moha.gov.vn
Bajaj Electricals Limited Attempts Reversal From Key SupportProtective Put Strategies & Diversify Intelligently to Avoid Big Hits - bollywoodhelpline.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Bloom Dekor Limited (526225) Announces Strategic ShiftMoving Average Crossovers & Free Stop-Loss Planning for Your Portfolio - bollywoodhelpline.com
BOLT SEC FilingsBolt Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Bolt Biotherapeutics (NASDAQ:BOLT) Share Price Passes Below Two Hundred Day Moving Average – What’s Next? - Defense World
Why Bolt Biotherapeutics Inc. stock could rally in 2025Trade Analysis Report & Free Safe Entry Trade Signal Reports - Улправда
Published on: 2025-12-21 07:10:36 - Улправда
What analyst consensus says on Bolt Biotherapeutics Inc. stockDay Trade & High Accuracy Buy Signal Tips - Улправда
Published on: 2025-12-20 08:01:52 - Улправда
Will Bolt Biotherapeutics Inc. stock rally after Fed decisionsDollar Strength & Verified High Yield Trade Plans - Улправда
Will Bolt Biotherapeutics Inc. stock beat EPS estimatesGDP Growth & Risk Controlled Swing Alerts - DonanımHaber
Shorts Report: Is Bolt Biotherapeutics Inc. stock vulnerable to regulatory risksMarket Risk Report & Daily Oversold Stock Bounce Ideas - DonanımHaber
Layoff Tracker: Voyager Loses 30 Employees After Novartis Prunes Deal - BioSpace
Is Bolt Biotherapeutics Inc. (6LP0) stock undervalued at current price2025 Pullback Review & Entry and Exit Point Strategies - Улправда
Published on: 2025-12-19 09:21:25 - Улправда
Aug Intraday: Is Bolt Biotherapeutics Inc. stock trading at a premium valuation2025 Risk Factors & Precise Trade Entry Recommendations - Улправда
Investor Mood: Why Bolt Biotherapeutics Inc. stock could rally in 2025Insider Buying & Expert Approved Trade Ideas - Улправда
Is Bolt Biotherapeutics Inc. stock trading at a premium valuationBreakout Watch & Long-Term Growth Plans - Улправда
Cash per share of Bolt Biotherapeutics, Inc. – BER:6LP0 - TradingView — Track All Markets
Bolt Biotherapeutics (BOLT) director files insider option changes on Form 4 - Stock Titan
Bolt Biotherapeutics (BOLT) reports director stock option replacement details - Stock Titan
Bolt Biotherapeutics (BOLT) details director stock option grants, repricing - Stock Titan
Bolt Biotherapeutics (BOLT) director reports option cancellations and new $5.44 grants - Stock Titan
Bolt Biotherapeutics (BOLT) executive swaps options for lower strike - Stock Titan
Bolt Biotherapeutics (BOLT) COO swaps options for lower strike price - Stock Titan
Financial Review: Acumen Pharmaceuticals (NASDAQ:ABOS) versus Bolt Biotherapeutics (NASDAQ:BOLT) - Defense World
What drives Bolt Biotherapeutics Inc stock priceMACD Histogram Signals & Outstanding Profit Strategies - earlytimes.in
Protagonist Therapeutics, Inc. (PTGX): A Bull Case Theory - Finviz
What technical signals suggest for Bolt Biotherapeutics Inc. stockTrade Entry Report & Free Verified High Yield Trade Plans - Newser
Will Bolt Biotherapeutics Inc. stock continue dividend increasesWeekly Gains Report & Accurate Entry/Exit Alerts - Newser
Bolt Biotherapeutics2025 Funding Rounds & List of Investors - Tracxn
Revenue per share of Bolt Biotherapeutics, Inc. – MUN:6LP0 - TradingView
Risk Check: Will Bolt Biotherapeutics Inc. stock outperform tech sector in 2025IPO Watch & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Risk Recap: Why Bolt Biotherapeutics Inc. stock could rally in 2025July 2025 Momentum & Weekly Watchlist for Consistent Profits - moha.gov.vn
Bolt Biotherapeutics (BOLT) Stock Forecast and Price Target 2025 - MarketBeat
Triple Negative Breast Cancer Clinical Trial Landscape Expands With 170+ Emerging Therapies, Reveals DelveInsight - The Globe and Mail
Finanzdaten der Bolt Biotherapeutics Inc-Aktie (BOLT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bolt Biotherapeutics Inc-Aktie (BOLT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Quinn William P. | President, CEO and CFO |
Jun 06 '25 |
Buy |
5.49 |
125 |
686 |
2,188 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):